Cargando…

Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia

Aims. Diabetes mellitus is a growing health problem worldwide. This study aimed to describe dysglycaemia and determine the impact of body composition and clinical and lifestyle factors on the risk of progression or regression from impaired fasting glucose (IFG) to diabetes or normoglycaemia in Austr...

Descripción completa

Detalles Bibliográficos
Autores principales: de Abreu, L., Holloway, Kara L., Kotowicz, Mark A., Pasco, Julie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530268/
https://www.ncbi.nlm.nih.gov/pubmed/26273669
http://dx.doi.org/10.1155/2015/373762
_version_ 1782384888019681280
author de Abreu, L.
Holloway, Kara L.
Kotowicz, Mark A.
Pasco, Julie A.
author_facet de Abreu, L.
Holloway, Kara L.
Kotowicz, Mark A.
Pasco, Julie A.
author_sort de Abreu, L.
collection PubMed
description Aims. Diabetes mellitus is a growing health problem worldwide. This study aimed to describe dysglycaemia and determine the impact of body composition and clinical and lifestyle factors on the risk of progression or regression from impaired fasting glucose (IFG) to diabetes or normoglycaemia in Australian women. Methods. This study included 1167 women, aged 20–94 years, enrolled in the Geelong Osteoporosis Study. Multivariable logistic regression was used to identify predictors for progression to diabetes or regression to normoglycaemia (from IFG), over 10 years of follow-up. Results. At baseline the proportion of women with IFG was 33.8% and 6.5% had diabetes. Those with fasting dysglycaemia had higher obesity-related factors, lower serum HDL cholesterol, and lower physical activity. Over a decade, the incidence of progression from IFG to diabetes was 18.1 per 1,000 person-years (95% CI, 10.7–28.2). Fasting plasma glucose and serum triglycerides were important factors in both progression to diabetes and regression to normoglycaemia. Conclusions. Our results show a transitional process; those with IFG had risk factors intermediate to normoglycaemics and those with diabetes. This investigation may help target interventions to those with IFG at high risk of progression to diabetes and thereby prevent cases of diabetes.
format Online
Article
Text
id pubmed-4530268
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-45302682015-08-13 Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia de Abreu, L. Holloway, Kara L. Kotowicz, Mark A. Pasco, Julie A. J Diabetes Res Research Article Aims. Diabetes mellitus is a growing health problem worldwide. This study aimed to describe dysglycaemia and determine the impact of body composition and clinical and lifestyle factors on the risk of progression or regression from impaired fasting glucose (IFG) to diabetes or normoglycaemia in Australian women. Methods. This study included 1167 women, aged 20–94 years, enrolled in the Geelong Osteoporosis Study. Multivariable logistic regression was used to identify predictors for progression to diabetes or regression to normoglycaemia (from IFG), over 10 years of follow-up. Results. At baseline the proportion of women with IFG was 33.8% and 6.5% had diabetes. Those with fasting dysglycaemia had higher obesity-related factors, lower serum HDL cholesterol, and lower physical activity. Over a decade, the incidence of progression from IFG to diabetes was 18.1 per 1,000 person-years (95% CI, 10.7–28.2). Fasting plasma glucose and serum triglycerides were important factors in both progression to diabetes and regression to normoglycaemia. Conclusions. Our results show a transitional process; those with IFG had risk factors intermediate to normoglycaemics and those with diabetes. This investigation may help target interventions to those with IFG at high risk of progression to diabetes and thereby prevent cases of diabetes. Hindawi Publishing Corporation 2015 2015-07-27 /pmc/articles/PMC4530268/ /pubmed/26273669 http://dx.doi.org/10.1155/2015/373762 Text en Copyright © 2015 L. de Abreu et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
de Abreu, L.
Holloway, Kara L.
Kotowicz, Mark A.
Pasco, Julie A.
Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_full Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_fullStr Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_full_unstemmed Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_short Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_sort dysglycaemia and other predictors for progression or regression from impaired fasting glucose to diabetes or normoglycaemia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530268/
https://www.ncbi.nlm.nih.gov/pubmed/26273669
http://dx.doi.org/10.1155/2015/373762
work_keys_str_mv AT deabreul dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia
AT hollowaykaral dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia
AT kotowiczmarka dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia
AT pascojuliea dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia